How long can precision medicine still be fired: Is the industry still in the education market?

For the newly added 4.3 million cancer patients in China every year, the development of precision medicine has become the dawn of life.

Recently, however, Tumor Precision Medicine was published in the "Nature" and "New England Journal of Medicine" two articles on the trial stage, alleged that "precision strategy does not bring benefits to most cancer patients, accurate treatment of tumors only It is a hypothesis to be proved." This view has caused great controversy in the domestic medical community, and there are also those who agree and have rebuttals.

"Targeted therapy has shown very good results in some tumors. Although there are still few targeted drugs, the future must be the highlight of precision medicine. But today's targeted therapy is not all of precision medicine, tumor precision medical treatment It should be a combination of various treatments such as surgery, radiotherapy, chemotherapy and biological therapy (targeted therapy, immunotherapy)." Zhan Qimin, an academician of the Chinese Academy of Engineering and an important promoter of precision medicine in China, expressed the above views.

How long can precision medicine still be fired: Is the industry still in the education market?

So, what is the current effect of precision medical treatment in China? Is there a bubble in cancer precision medicine? Today's "Genetic Tao" to discuss this topic.

How does tumor precision medicine work?

Precision medicine is relative to traditional medicine. Zhu Ming, chief information officer of Cloud Health Gene Technology, said that precision medicine first divided the crowd into the best, so that everyone could get the best treatment plan. In addition to cancer, the concept of precision medicine is gradually extending to various chronic diseases such as diabetes and cardiovascular disease.

How does precision medicine reflect personalization? For example, a liquid biopsy applied to tumor personalized guidance medication and drug resistance tracking, a patient with a confirmed tumor does not know which drugs may be effective before genetic testing, and only after the patient fails to test, the drug is changed. It is a great injury and delays the precious treatment time of cancer patients.

Now, in hospitals that use liquid biopsy, patients can perform gene sequencing through a tube of blood and select the most appropriate tumor-targeted drug based on the patient's genetic mutation. At the same time, resistance tracking can also be carried out. In the treatment, once the patient is resistant, the tumor will recur, and the patient can continue to guide the patient to treat and control the second-generation targeted drug through gene sequencing.

If personalized treatment can be achieved, it will not only improve patient survival, but also save a lot of medical expenses. Of course, the current cancer precision medicine is in its infancy, both in the United States and China. In addition to the sensitivity problem to be solved by liquid biopsy, the problem facing domestic cancer precision medicine is that there are fewer targeted drugs.

Zhou Xiangjun, chief scientist of Hengruiyuan, who is aiming at the precise treatment of tumors, told the First Financial Reporter that even if genetic testing can detect genetic mutations in cancer patients, domestic targeted drug selection is difficult, and cancer patients can choose only drugs in China. Several, many targeted drugs (in the second phase of the research drug) are not listed in China, can only go to India to buy generic drugs, many drugs are not indications for patients, need to use across indications, such as patients with bowel cancer, Pfizer's Gentinib is aimed at lung cancer. Cross-adapted symptoms are allowed in the United States. China has no regulations and may cause medical disputes, so Chinese doctors will not prescribe this drug to patients. Of course, there are dozens of targeted drugs available in the United States, so some cancer patients choose to seek medical treatment overseas, but the cost is not affordable for ordinary people.

First Aid Bandage

First Aid Bandage,Breathable Elastic Pbt Bandage,Disposable First Aid Bandages,Medical Sterile Bandages

Shaoxing Weijian Medical Supplies Co.,Ltd. , https://www.wetourmedical.com